A detailed history of Manufacturers Life Insurance Company, The transactions in Novavax Inc stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 79,783 shares of NVAX stock, worth $736,397. This represents 0.0% of its overall portfolio holdings.

Number of Shares
79,783
Previous 59,656 33.74%
Holding current value
$736,397
Previous $755,000 33.38%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$10.71 - $17.11 $215,560 - $344,372
20,127 Added 33.74%
79,783 $1.01 Million
Q2 2024

Aug 14, 2024

BUY
$3.89 - $20.97 $80,558 - $434,267
20,709 Added 53.17%
59,656 $755,000
Q1 2024

May 14, 2024

BUY
$3.76 - $6.02 $15,130 - $24,224
4,024 Added 11.52%
38,947 $186,000
Q4 2023

Feb 13, 2024

BUY
$4.8 - $7.67 $2,760 - $4,410
575 Added 1.67%
34,923 $167,000
Q2 2023

Aug 11, 2023

BUY
$6.67 - $9.52 $229,101 - $326,992
34,348 New
34,348 $255,000
Q4 2021

Feb 16, 2022

SELL
$134.56 - $217.97 $174,658 - $282,925
-1,298 Closed
0 $0
Q2 2021

Aug 12, 2021

SELL
$121.0 - $257.67 $4 Million - $8.53 Million
-33,089 Reduced 96.23%
1,298 $276,000
Q1 2021

May 03, 2021

SELL
$112.98 - $319.93 $250,024 - $708,005
-2,213 Reduced 6.05%
34,387 $6.24 Million
Q4 2020

Feb 12, 2021

BUY
$78.74 - $139.5 $111,495 - $197,532
1,416 Added 4.02%
36,600 $4.08 Million
Q3 2020

Nov 09, 2020

BUY
$79.44 - $178.51 $93,262 - $209,570
1,174 Added 3.45%
35,184 $3.81 Million
Q2 2020

Aug 10, 2020

BUY
$13.86 - $83.61 $196,895 - $1.19 Million
14,206 Added 71.73%
34,010 $2.84 Million
Q1 2020

May 15, 2020

BUY
$3.93 - $16.0 $16,718 - $68,064
4,254 Added 27.36%
19,804 $269,000
Q4 2019

Feb 14, 2020

SELL
$3.69 - $5.22 $2,512 - $3,554
-681 Reduced 4.2%
15,550 $62,000
Q2 2019

Aug 14, 2019

BUY
$4.93 - $12.2 $80,018 - $198,018
16,231 New
16,231 $95,000

Others Institutions Holding NVAX

About NOVAVAX INC


  • Ticker NVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,215,104
  • Market Cap $722M
  • Description
  • Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...
More about NVAX
Track This Portfolio

Track Manufacturers Life Insurance Company, The Portfolio

Follow Manufacturers Life Insurance Company, The and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.